Why Are Participants in Novavax's COVID Vaccine Study Receiving 2 Extra Shots?

Like most of the other COVID-19 vaccines that have already won Emergency Use Authorization (EUA), Novavax's (NASDAQ: NVAX) vaccine requires two shots spread several weeks apart. In this Motley Fool Live video recorded on April 7, Motley Fool contributors Keith Speights and Brian Orelli talk about why Novavax is making this move. Keith Speights: Novavax, the ticker there is NVAX, recently announced that it has initiated crossover arms with its late-stage studies that are going on in the United Kingdom, and in the U.S. and Mexico.